Biointron Biological USA Inc.
Piscataway, NJ
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 121 Ethel Rd W Ste 6A, Piscataway, NJ 08854, USA
- Website
- biointron.com
- Founded
- 2012
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $49,800 |
| FY2025 | $0 |
| FY2024 | $49,946 |
| FY2023 | $16,346 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $49,800 |
Contract awards
Similar vendors
About the company
Biointron Biological USA Inc., a self-certified small disadvantaged business based in Piscataway, New Jersey, provides antibody expression and nanobody screening services to the National Institutes of Health as a prime contractor under Total Small Business set-asides and full-and-open competitive awards. The vendor operates exclusively as a prime; all four recent awards are direct purchase orders with no subcontract activity. Biointron's work centers on recombinant antibody production and discovery-stage biologics support, with performance locations in Bethesda, Maryland and Metuchen, New Jersey.
Customer concentration is tight. The National Institute of Allergy and Infectious Diseases accounts for 3 awards totaling $77 thousand (61% of combined potential value), while the National Institute of Child Health and Human Development accounts for 1 award worth $50 thousand (39% of combined potential value) — both institutes sit under the Department of Health and Human Services National Institutes of Health. Representative work includes a $49.8 thousand Total Small Business purchase order from NICHD (September 2026) for nanobody screening and anti-human NPR-C VHH antibody discovery under Project 9PKWNH001, running through September 2027; a $49.9 thousand full-and-open purchase order from NIAID (July 2024) for antibody expression services, completed July 2025; and a $16.3 thousand NIAID purchase order (September 2023) for antibody expression services. Award frequency has been light — one purchase order per year from 2022 through 2024, then one in September 2026 — totaling $127 thousand across four awards since September 2022. One award (the NICHD nanobody screening work) faces completion in the next twenty-four months, carrying $50 thousand in potential recompete exposure.
Quick answers
Is Biointron Biological USA Inc. registered in SAM.gov?
Yes. Biointron Biological USA Inc.'s SAM.gov registration is active through August 10, 2027.
What is Biointron Biological USA Inc.'s CAGE code?
Biointron Biological USA Inc.'s CAGE code is 98RQ4, and its Unique Entity ID (UEI) is K4YNFPMLJSJ4.
How much has Biointron Biological USA Inc. received in federal contracts?
Federal contracts obligated $116,092 to Biointron Biological USA Inc. in fiscal years 2023 through 2027.
What is Biointron Biological USA Inc.'s most recent federal award?
Biointron Biological USA Inc.'s most recent federal contract award is Nichd: nanobody screening for anti-human NPR-C VHH antibody discovery. Project ID: 9PKWNH001. Reference quote… (75N98026P01504), from Office of Logisitics and Acquisition Operations (NIH), on September 4, 2026.
On GovTribe
See Biointron Biological USA Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors